An application of FTIR spectroscopic imaging for the identification and visualization of early micrometastasis from breast cancer to lungs in a murine model is shown. Spectroscopic and histological examination is focused on lung cross-sections derived from animals at the early phase of metastasis (early micrometastasis, EM) as compared to healthy control (HC) and late phase of metastasis (advanced macrometastasis, AM) using murine model of metastatic breast cancer with 4T1 cells orthotopically inoculated. FTIR imaging allows for a detailed, objective and label-free differentiation and visualization of EM foci including large and small micrometastases as well as single cancer cells grouped in clusters. An effect of the EM phase on the entire lung tissue matrix as well as characteristic biochemical profiles for HC and advanced macrometastasis were determined from morphological and spectroscopic points of view. The extraordinary sensitivity of FTIR imaging toward EM detection and discrimination of AM borders confirms its applicability as a complementary tool for the histopathological assessment of the metastatic cancer progression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbadis.2018.08.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer.
Cancers (Basel)
December 2024
Department of Surgical Sciences, Division of Gynaecology and Obstetrics, University of Cagliari, 09042 Cagliari, Italy.
: This study investigates which demographic, clinical and pathological factors of women with early-stage presurgical EC could be considered risk factors for the presence of different subtypes of metastases in sentinel lymph nodes (SLNs). : This is a retrospective single-center study that collected data between December 2015 and April 2024. EC patients who underwent total hysterectomy with salpingo-oophorectomy and SLN mapping with indocyanine green (ICG) were recorded.
View Article and Find Full Text PDFOxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer.
Biomolecules
October 2024
Gruop Multidisciplinar de Oncología Traslacional, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, 07122 Palma de Mallorca, Spain.
Oxaliplatin is successfully used on advanced colorectal cancer to eradicate micro-metastasis, whereas its benefits in the early stages of colorectal cancer remains controversial since approximately 30% of patients experience unexpected relapses. Herein, we evaluate the efficacy of oxidative phosphorylation as a predictive biomarker of oxaliplatin response in colorectal cancer. We found that non-responding patients exhibit low oxidative phosphorylation activity, suggesting a poor prognosis.
View Article and Find Full Text PDFIn vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasis.
Sci Bull (Beijing)
October 2024
NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin Medical University, Harbin 150001, China. Electronic address:
Article Synopsis
- * bsProbe shows significantly improved tumor accumulation—about six times more than traditional probes—enhancing detection capabilities for small tumors and providing a clearer distinction between malignant and benign tissues.
- * With a specificity of 90.48% and sensitivity of 92.22% based on analysis of 195 bladder cancer specimens, the bsProbe could improve early diagnosis and may aid in imaging-guided surgeries for tumors that are not visible.
Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence-Based Review.
Cancer Med
October 2024
Department of Radiation Oncology, GenesisCare, Hospital Universitario Vithas Madrid La Milagrosa, Madrid, Spain.
Introduction: Historically, multimodal therapeutic strategies involving preoperative chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (CT) have been employed to treat locally advanced rectal cancer (LARC). Total Neoadjuvant Therapy (TNT) is showing promise in improving outcomes. Despite its benefits, the optimal sequencing within TNT-whether induction chemotherapy should precede or follow chemoradiotherapy-remains a critical question.
View Article and Find Full Text PDFLeveraging PARP-1/2 to Target Distant Metastasis.
Int J Mol Sci
August 2024
Faculty of Medicine, Université de Montréal, Montreal, QC H3C 3T5, Canada.
Poly (ADP-Ribose) Polymerase (PARP) inhibitors have changed the outcomes and therapeutic strategy for several cancer types. As a targeted therapeutic mainly for patients with mutations, PARP inhibitors have commonly been exploited for their capacity to prevent DNA repair. In this review, we discuss the multifaceted roles of PARP-1 and PARP-2 beyond DNA repair, including the impact of PARP-1 on chemokine signalling, immune modulation, and transcriptional regulation of gene expression, particularly in the contexts of angiogenesis and epithelial-to-mesenchymal transition (EMT).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!